Article Information
History
- December 9, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Peter D. Galer1,2,3,4,
- Shridhar Parthasarathy1,2,3,
- Julie Xian1,2,3,
- Jillian L. McKee1,3,5,
- Sarah M. Ruggiero1,3,
- Shiva Ganesan1,2,3,
- David Lewis-Smith1,2,6,7,
- Michael C. Kaufman1,2,3,
- Stacey R. Cohen1,3,
- Scott Haag2,
- Alexander K. Gonzalez2,
- Olivia Wilmarth1,3,
- Colin A. Ellis3,5,
- Brian Litt4,5 and
- Ingo Helbig1,2,3,5,*
- 1Division of Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
- 2Department of Biomedical and Health Informatics (DBHi), Children’s Hospital of Philadelphia, Philadelphia, PA, USA
- 3The Epilepsy NeuroGenetics Initiative (ENGIN), Children’s Hospital of Philadelphia, Philadelphia, PA, USA
- 4University of Pennsylvania, Center for Neuroengineering and Therapeutics, Philadelphia, PA, USA
- 5Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 6Translational and Clinical Research Institute, Newcastle University, UK
- 7Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK
- ↵*Correspondence to: Ingo Helbig, MD, 3401 Civic Center Blvd, Philadelphia, PA 19104, helbigi{at}chop.edu
Posted December 09, 2022.
Clinical signatures of genetic epilepsy precede diagnosis in electronic medical records of 32,000 individuals
